Patients affected by Type 2 Diabetes & Atrial fibrillation with history of systolic heart failure have a higher risk for cardiogenic shock & death during hospitalization. - 30/10/21
Abstract |
Introduction |
Several studies show a strong correlation between diabetes (DM) & atrial fibrillation (AF). Similarly, heart failure (HF) is associated among patients with AF. The purpose of this study was to examine the impact of systolic (SHF) vs diastolic heart failure (DHF) on clinical outcomes in patients with concomitant AF & DM.
Methods |
We queried the National Inpatient Sample (NIS) 2017 & 2018 for patients with DM & AF as a principal diagnosis with SHF or DHF as a secondary diagnosis. The primary outcome was mortality and cardiac arrest, cardiogenic shock (CS), & length of stay (LOS) were secondary. A multivariable logistic regression analysis estimated clinical outcomes & a p-value of <0.05 was significant.
Results |
107,530 patients with DM & AF were admitted with 48% having HF (66% SHF & 34% DHF). SHF vs DHF cohorts were mean age of 71.2 years [CI 70.9-71.5] vs 73.3 years [CI 72.9-73.6], Males (70.2% vs 53.8%), Females (29.8% vs 46.2%), Whites (70.5% vs 71.2%), Black (17% vs 16%), & Hispanic (8.7% vs 8.5%) . SHF showed a significantly higher mortality (2.65% vs 2.13%, p<0.05) & cardiogenic shock (0.78% vs 0.32%, p=0.005) compared to DHF (Table 1). There was no significant differences in other outcomes.
Le texte complet de cet article est disponible en PDF.
Vol 242
P. 164 - décembre 2021 Retour au numéro
Article précédent
- Evaluation of the beneficial effect of metformin on clinical indicators of heart failure patients with coronary artery disease and impaired glucose tolerance within a 12-month follow-up
- B. Kurmanbekova, A. Noruizbaeva, G. Osmankulova, A. Rustambekova
- Statin and Icosapent Ethyl Use and Lipid Control in US Adults with Diabetes According to DM Risk Groups, Sex and Ethnicity in the NIH Precision Medicine Initiative All of Us Study
- Meleeka Akbarpour, Divya Devineni, Yufan Gong, Nathan D. Wong
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?